Literature DB >> 19214865

Prevalence of symptoms suggestive of extra-oesophageal reflux in a general practice population in the UK.

Martyn Lowden1, Julian A McGlashan, Alison Steel, Vicki Strugala, Peter W Dettmar.   

Abstract

Unlike gastro-oesophageal reflux, extra-oesophageal reflux (EOR) is not necessarily associated with heartburn. The potential prevalence of EOR in general practice in the UK using the Reflux Symptom Index (RSI) questionnaire was determined. A total of 1152 patients attending a GP surgery for routine conditions completed the RSI questionnaire: 26.5% had an RSI score >10, regarded as a clinically significant score for EOR; 29% of patients with a significant RSI score rated the impact of heartburn in the previous month as zero. Significant numbers of patients presenting to GPs have high RSI scores suggesting significant reflux. Many patients likely to have EOR do not experience classical heartburn. This might explain why some GPs may not attribute common symptoms affecting the throat to gastric reflux.

Entities:  

Mesh:

Year:  2009        PMID: 19214865     DOI: 10.1080/14015430902735847

Source DB:  PubMed          Journal:  Logoped Phoniatr Vocol        ISSN: 1401-5439            Impact factor:   1.487


  7 in total

1.  Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux.

Authors:  Mark D Wilkie; Helen M Fraser; Hemal Raja
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-30       Impact factor: 2.503

2.  Prevention of esophagopharyngeal reflux by augmenting the upper esophageal sphincter pressure barrier.

Authors:  Reza Shaker; Arash Babaei; Sohrab R Naini
Journal:  Laryngoscope       Date:  2014-06-27       Impact factor: 3.325

3.  Comparative effect of the sites of anterior cervical pressure on the geometry of the upper esophageal sphincter high-pressure zone.

Authors:  Ling Mei; Hongmei Jiao; Tarun Sharma; Arshish Dua; Patrick Sanvanson; Sudarshan R Jadcherla; Reza Shaker
Journal:  Laryngoscope       Date:  2017-05-23       Impact factor: 3.325

4.  The prevalence of laryngopharyngeal reflux in the English population.

Authors:  Tawakir Kamani; Susannah Penney; Indu Mitra; Vijay Pothula
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-11       Impact factor: 2.503

5.  Laryngopharyngeal reflux disease in the Greek general population, prevalence and risk factors.

Authors:  Nikolaos Spantideas; Eirini Drosou; Anastasia Bougea; Dimitrios Assimakopoulos
Journal:  BMC Ear Nose Throat Disord       Date:  2015-12-21

6.  TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.

Authors:  Gillian Watson; James O'Hara; Paul Carding; Jan Lecouturier; Deborah Stocken; Tony Fouweather; Janet Wilson
Journal:  Trials       Date:  2016-04-01       Impact factor: 2.279

7.  Use of proton pump inhibitors to treat persistent throat symptoms: multicentre, double blind, randomised, placebo controlled trial.

Authors:  James O'Hara; Deborah D Stocken; Gillian C Watson; Tony Fouweather; Julian McGlashan; Kenneth MacKenzie; Paul Carding; Yakubu Karagama; Ruth Wood; Janet A Wilson
Journal:  BMJ       Date:  2021-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.